Physicians' Academy for Cardiovascular Education

Clinical outcomes of GLP-1RA in kidney disease: Current evidence and ongoing trials

10' education - July 12, 2019 - ERA-EDTA 2019 - Frederik Persson, MD – Copenhagen, Denmark - Online CME

Frederik Persson shows evidence of renoprotective effects with GLP-1RA treatment, by discussing various small clinical trials as well as CVOTs with GLP-1RAs.

Video navigation menu

  • Trials and studies on GLP-1RAs in renal patient populations 1:19
  • Renal outcomes with GLP-1RAS in various trials 6:21
  • Ongoing trials with GLP-1RAs examining renal outcomes 11:45

Educational information

This lecture by Frederik Persson was part of a CME-accredited symposium "Impacting progression and outcomes of DKD: Translating novel insights with GLP-1 RA to practice" held during ERA EDTA 2019 in Budapest, Hungary.


Frederik Persson, MD, Senior researcher at Steno Diabetes Center, Copenhagen, Denmark.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk A/S.

View slides of the presentation


This is available as accredited online CME for members. Click the button below to enroll:

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: